Consolidated Portfolio Review Corp Stryker Corp Transaction History
Consolidated Portfolio Review Corp
- $723 Billion
- Q2 2025
A detailed history of Consolidated Portfolio Review Corp transactions in Stryker Corp stock. As of the latest transaction made, Consolidated Portfolio Review Corp holds 648 shares of SYK stock, worth $239,274. This represents 0.04% of its overall portfolio holdings.
Number of Shares
648
Previous 622
4.18%
Holding current value
$239,274
Previous $231 Million
10.69%
% of portfolio
0.04%
Previous 0.04%
Shares
6 transactions
Others Institutions Holding SYK
# of Institutions
2,528Shares Held
298MCall Options Held
1.38MPut Options Held
1.04M-
Vanguard Group Inc Valley Forge, PA33.5MShares$12.4 Billion0.22% of portfolio
-
Black Rock Inc. New York, NY26.8MShares$9.9 Billion0.21% of portfolio
-
Greenleaf Trust Kalamazoo, MI16.7MShares$6.16 Billion58.77% of portfolio
-
State Street Corp Boston, MA15MShares$5.52 Billion0.23% of portfolio
-
Jpmorgan Chase & CO New York, NY12.6MShares$4.66 Billion0.37% of portfolio
About STRYKER CORP
- Ticker SYK
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 378,320,992
- Market Cap $140B
- Description
- Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. This segment also offers spinal implant products c...